Carbidopa/Levodopa XR: The Essential Guide

Carbidopa/Levodopa XR is an extended-release oral tablet used to treat Parkinson's disease by replenishing dopamine levels in the brain. It combines two active ingredients — Levodopa (a dopamine precursor) and Carbidopa (which prevents Levodopa from breaking down too early) — in a slow-release formulation designed to provide smoother, longer-lasting symptom control.

If you or someone you care about has been prescribed this medication, here's everything you need to know.

What Is Carbidopa/Levodopa XR?

Carbidopa/Levodopa XR belongs to a class of medications called dopaminergic antiparkinsonism agents. Here are the key details:

• Generic name: Carbidopa and Levodopa Extended-Release Tablets
• Brand name: Sinemet CR (now discontinued; only generic versions remain). Related brand products include Rytary (extended-release capsules) and Duopa (enteral suspension).
• Drug class: Dopaminergic antiparkinsonism agent
• Manufacturers: Multiple generic manufacturers including Accord, Sun Pharma, and others
• FDA approval: Originally approved as Sinemet CR for Parkinson's disease
• Controlled substance: No — Carbidopa/Levodopa XR is not a controlled substance and has no DEA schedule

The "XR" or "CR" designation means the tablet is formulated to release medication gradually over several hours, rather than all at once. This can reduce the peaks and valleys in dopamine levels that cause motor fluctuations — the "on-off" phenomenon familiar to many Parkinson's patients.

What Is It Used For?

Carbidopa/Levodopa XR is FDA-approved for:

• Parkinson's disease — The primary and most common use. It treats motor symptoms including tremor, rigidity, slowness of movement (bradykinesia), and balance problems.
• Post-encephalitic parkinsonism — Parkinsonism symptoms that develop after a brain infection.
• Symptomatic parkinsonism from carbon monoxide or manganese exposure.

It's also used off-label for:

• Restless legs syndrome (RLS)
• Dopa-responsive dystonia

Levodopa-based medications remain the gold standard for Parkinson's treatment and are generally the most effective option for controlling motor symptoms.

How Is It Taken?

Getting the dosing right matters with Carbidopa/Levodopa XR. Here's what you need to know:

Available Strengths

• 25 mg Carbidopa / 100 mg Levodopa extended-release tablets
• 50 mg Carbidopa / 200 mg Levodopa extended-release tablets

Typical Dosing

The usual dose is one tablet taken two to four times daily, with doses spaced four to eight hours apart during waking hours. The maximum recommended dose is eight tablets per day. Your doctor will start you on a lower dose and adjust based on your response.

How to Take It

• Swallow tablets whole. Do not crush, chew, or split extended-release tablets — doing so destroys the slow-release mechanism and can cause too much medication to be released at once.
• Take with or without food. Taking it with food increases absorption by about 50%. However, high-protein meals may reduce Levodopa absorption by competing for transport across the gut and into the brain.
• Space doses evenly throughout the day during waking hours.
• Never stop abruptly. Suddenly stopping Carbidopa/Levodopa XR can cause a dangerous condition resembling neuroleptic malignant syndrome, with high fever and muscle rigidity. Always taper under medical supervision.

Who Should Not Take It?

Carbidopa/Levodopa XR is not safe for everyone. It is contraindicated in:

• People taking nonselective MAO inhibitors (such as Phenelzine or Tranylcypromine) within the last 14 days — risk of hypertensive crisis
• People with narrow-angle glaucoma
• People with a known allergy to Carbidopa or Levodopa
• People with suspicious undiagnosed skin lesions or a history of melanoma

It should be used with caution in patients with severe cardiovascular, pulmonary, kidney, liver, or endocrine disease. It is not recommended for patients under 18 years old. Pregnant women should discuss risks with their doctor, as it is classified as Pregnancy Category C.

For a full list of medications to avoid, see our guide on Carbidopa/Levodopa XR drug interactions.

How Much Does It Cost?

The good news: generic Carbidopa/Levodopa XR is relatively affordable.

• Cash price: $30 to $80 for a 30-day supply without insurance
• With coupons: As low as $29 for 60 tablets of the 25/100 mg strength through GoodRx
• With insurance: Most plans cover it as a Tier 1 or Tier 2 preferred generic, meaning low copays — often $0 to $15 per month

Generic Carbidopa/Levodopa ER is covered by Medicare Part D, Medicaid, and most commercial insurance plans. It generally does not require prior authorization. Some plans may limit you to eight tablets per day.

If cost is a concern, check out our detailed guide on how to save money on Carbidopa/Levodopa XR, which covers coupon cards, discount programs, and patient assistance options.

How It Compares

For context, here's how Carbidopa/Levodopa XR stacks up against related medications:

• Carbidopa/Levodopa immediate-release (Sinemet): $9 to $15/month — cheaper but requires more frequent dosing
• Stalevo (Carbidopa/Levodopa/Entacapone): $54 to $100/month with coupon — adds Entacapone to extend the effect
• Rytary (brand ER capsules): $800 to $1,500/month without insurance — smoother delivery but much more expensive
• Pramipexole or Ropinirole (dopamine agonists): $10 to $30/month — different mechanism, different side effect profile

For a full comparison, see our guide on alternatives to Carbidopa/Levodopa XR.

Final Thoughts

Carbidopa/Levodopa XR remains one of the most important medications for managing Parkinson's disease. It's effective, relatively affordable, and widely covered by insurance. The extended-release formulation can help smooth out the motor fluctuations that come with Parkinson's, giving you more consistent symptom control throughout the day.

If you've been prescribed Carbidopa/Levodopa XR, learn about the side effects to watch for, and use Medfinder to find a pharmacy that has it in stock near you.